等待开盘 10-30 09:30:00 美东时间
-0.340
-2.19%
DBV Technologies shares are trading lower. The company reported Q3 financial re...
10-29 21:02
Shares of Teradyne Inc (NASDAQ:TER) rose sharply in today's pre-market trading ...
10-29 17:05
U.S. stocks were higher, with the Nasdaq Composite gaining more than 50 points ...
10-16 22:17
DBV Technologies (NASDAQ:DBVT) announced on Monday that it has agreed to issue and sell new ordinary shares in the form of American Depositary Shares ((ADSs)) for total gross proceeds of $30 million t...
10-07 05:14
DBV Technologies announced the sale of approximately $30 million of ADSs under its At-The-Market (ATM) Program on Nasdaq. The offering involved issuing 11,538,460 new ordinary shares (underlying 2,307,692 ADSs) at $13.00 per ADS, representing a 3.41% discount to the last closing price on Euronext Paris. The new shares will dilute existing shareholders by 7.77% and represent 8.42% of the existing shares on Euronext Paris. Invus, holding 13,857,460...
10-06 21:02
DBV Technologies SA – American ( ($DBVT) ) has issued an update. On September 1...
09-19 04:56
This week's biggest movers among financial stocks included crypto-linked firms, fintechs and housing-related names. Overall, the Financial Select Sector SPDR ETF (XLF) dipped 1.5% in the past five ses...
09-06 22:10
DBV Technologies (NASDAQ:DBVT) filed a prospectus supplement with the SEC for an at-the-market offering up to $150M of American Depositary Shares. Each ADS represents five ordinary shares of the compa...
09-06 04:59
DBV Technologies Establishes an At-The-Market (ATM) Program on NasdaqDBV Technologies (TRQX:DBVp) (the "Company"), a clinical-stage biopharmaceutical company, today announced that it has filed a prospectus supplement
09-06 04:34
DBV Technologies, a clinical-stage biopharmaceutical company, has announced the establishment of an at-the-market (ATM) program on the Nasdaq Capital Market, allowing it to offer and sell up to $150 million in American Depositary Shares (ADS). The proceeds will primarily support activities related to the Biologics License Application (BLA) for VIASKIN® Peanut patch in toddlers aged 1-3 years, as well as advance the development of other product ca...
09-05 20:30